TITLE

AXCELL/MUENSTER ALLIANCE TO RESEARCH PROTEIN INTERACTIONS

PUB. DATE
June 2002
SOURCE
Worldwide Biotech;Jun2002, Vol. 14 Issue 6, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the agreement signed by AxCell Biosciences with University of Muenster to research protein interactions associated with an undisclosed gene believed to play a role in neurodegenerative diseases.
ACCESSION #
6772515

 

Related Articles

  • AXCELL DEBUTS PROCHART PROTEIN INTERACTIONS DATABASE.  // Worldwide Databases;Jun2001, Vol. 13 Issue 6, p1 

    Reports on Axcell Biosciences Corp.'s introduction of the ProChart Database of protein interactions in the human body. Map of the interactions of the body's 60-80 protein domain families.

  • MAP OF WW PROTEIN DOMAIN HELPS TARGET HEALTH PROBLEMS.  // Online Product News;Jul2001, p1 

    Reports that the ProChart Database of protein interactions in the human body has been introduced in Europe by AxCell Biosciences Corp. Contents of the database; Marketing activities for ProChart Database.

  • STOCK TO WATCH: CYTOGEN. Ruth, Joao-Pierre S. // Business News New Jersey;01/16/2001, Vol. 14 Issue 3, p18 

    Presents a financial profile of Princeton, New Jersey-based biopharmaceutical company Cytogen Corp. Company subsidiary AxCell Biosciences' completion of the first-ever map of the interactions of a human protein family; AxCell's main competitors in the field; Potential applications of the...

  • AXCELL EXPLORES DISEASE PATHWAYS USING IBM DB2 TECHNOLOGY.  // Worldwide Databases;Oct2002, Vol. 14 Issue 10, pN.PAG 

    Reports that AxCell Biosciences is using IBM DB2 Intelligent Miner to help its scientists chart the communication pathways within cells that enable proteins to interact and cause or prevent disease. Features of IBM DB2 Intelligent Miner; Reason for using IBM database technology; System...

  • NEW TECHNOLOGY HELPS DRUG COMPANIES DESIGN SAFER DRUGS.  // Online Product News;Nov2002, pN.PAG 

    Discusses how the IBM DB2 Intelligent Miner, a database technology has helped the scientists of AxCell Biosciences, chart the communication pathways within cells. Features and capabilities of the technology; Reason for the decision of AxCell to utilize DB2; Systems biology approach of AxCell to...

  • R&D Bulletin.  // R&D Magazine;Nov2001, Vol. 43 Issue 11, p11 

    Presents updates on business enterprises as of November 2001. Details of BOC Edwards, Crawley company's acquisition of Smiths Group's Sealing Solutions division; Information on the joint venture of AxCell Biosciences and National Cancer Institute for cancer research; Features of ALCATEL Micro...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics